SCHEMBL17845256

SCHEMBL17845256

[O]c1ccc2c(c1)Oc1ccccc1C2

nearest known ligand 0.65

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.65
MAOB P27338 1/20 0.65
ACSL1 P33121 1/20 0.40
GAA P10253 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MAPKAPK2 P49137 1/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Xanthene SCHEMBL27837879 0.83 MAOA (0.85) MAOAMAOBACSL1GAANPSR1
SCHEMBL9455528 0.81 MAOA (0.81) MAOAMAOBACSL1GAANPSR1
Xanthene SCHEMBL9339684 0.81 MAOA (1.00) MAOAMAOBACSL1GAANPSR1
Xanthene SCHEMBL30586075 0.81 MAOA (1.00) MAOAMAOBACSL1GAANPSR1
Xanthene SCHEMBL29378346 0.81 MAOA (1.00) MAOAMAOBACSL1GAANPSR1
Xanthene SCHEMBL27493963 0.81 MAOA (1.00) MAOAMAOBACSL1GAANPSR1
Xanthene SCHEMBL4267 0.81 MAOA (1.00) MAOAMAOBACSL1GAANPSR1
SCHEMBL9455608 0.79 MAOA (0.77) MAOAMAOBACSL1GAANPSR1
Xanthene SCHEMBL27942350 0.79 MAOA (0.85) MAOAMAOBACSL1GAANPSR1
Xanthene SCHEMBL23355281 0.79 MAOA (0.94) MAOAMAOBACSL1GAANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3692053-A1 IMMUNOMODULATORS Bristol-Myers Squibb Company (US) 2020-08-12 EP disclosed
WO-2019070643-A1 IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2019-04-11 WO disclosed
EP-3423470-A1 IMMUNOMODULATORS Bristol-Myers Squibb Company (US) 2019-01-09 EP disclosed
EP-3233887-A1 IMMUNOMODULATORS Bristol-Myers Squibb Company (US) 2017-10-25 EP disclosed
WO-2016126646-A1 IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2016-08-11 WO disclosed
WO-2016100608-A1 IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2016-06-23 WO disclosed